Kai Hai Shao
Direktor/Vorstandsmitglied bei PENGQI TECHNOLOGY DEVELOPMENT CO., LTD.
Ursprung des Netzwerks ersten Grades von Kai Hai Shao
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Private Company | Industrial Machinery | 19 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kai Hai Shao
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CHINA OCEANWIDE HOLDINGS LIMITED | Real Estate Development | Director/Board Member | |
| Tongji University | College/University | Graduate Degree | |
| CHANGYUAN TECHNOLOGY GROUP LTD. | Miscellaneous Manufacturing | Director/Board Member | |
| ZHONGCHANG BIG DATA CORPORATION LIMITED | Advertising/Marketing Services | Director/Board Member | |
| SHANGHAI CHINAFORTUNE CO., LTD. | Investment Banks/Brokers | Director/Board Member | |
| ORIENT INTERNATIONAL ENTERPRISE, LTD. | Air Freight/Couriers | Director/Board Member | |
| Beijing University of Posts & Telecommunications | College/University | Doctorate Degree | |
| OCEANWIDE HOLDINGS CO., LTD. | Real Estate Development | Director/Board Member | |
| SHANGHAI FEILO ACOUSTICS CO.,LTD | Electronic Equipment/Instruments | Director/Board Member | |
| VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD. | Packaged Software | Director/Board Member Director of Finance/CFO Director/Board Member | |
| Fudan University | College/University | Corporate Officer/Principal | |
| GanNan Normal University | College/University | Undergraduate Degree | |
| Zhengzhou University | College/University | Undergraduate Degree | |
Zensun (Shanghai) Sci & Tech Co., Ltd.
 Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Chenzhou Fengyue Environmental Science & Technology Co., Ltd.
 Chenzhou Fengyue Environmental Science & Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chenzhou Fengyue Environmental Science & Technology Co., Ltd. engages in the recovery of copper, tin, lead, zinc, indium, cadmium, gold, silver, antimony, bismuth, and other non-ferrous metals from smelting waste residue, waste, and tailings slag. Its products include ingot, zinc ingot, gold ingot, silver ingot, iron powder, cadmiium ingot, and indium ingot. The company was founded on June 1, 2007 and is headquartered in Zixing, China. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| ZHONGTAI SECURITIES CO., LTD. | Investment Banks/Brokers | Director/Board Member | |
| HENAN QINGSHUIYUAN TECHNOLOGY CO.,LTD | Chemicals: Specialty | Director/Board Member | |
| TIANJIN JIEQIANG POWER EQUIPMENT CO.,LTD. | Electronic Production Equipment | Director/Board Member | |
Shanghai Pudong New Area Changjiang Dingli Microfin Co., Ltd.
 Shanghai Pudong New Area Changjiang Dingli Microfin Co., Ltd. Finance/Rental/LeasingFinance Shanghai Pudong New Area Changjiang Dingli Microfin Co., Ltd. engages in microfinancing. The company was founded on April 1, 2012 and is headquartered in Shanghai, China. | Finance/Rental/Leasing | Director/Board Member | |
Jilin Wanfang Baiao Biotechnology Co., Ltd.
 Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Pharmaceuticals: Major | Chairman |
Statistik
International
| China | 20 |
| Hong Kong | 2 |
Sektoral
| Finance | 6 |
| Consumer Services | 6 |
| Commercial Services | 3 |
| Electronic Technology | 3 |
| Health Technology | 3 |
Operativ
| Director/Board Member | 24 |
| Independent Dir/Board Member | 13 |
| Chairman | 8 |
| Corporate Secretary | 6 |
| Investor Relations Contact | 4 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Yi Wei | 7 |
| Fa Shan Yan | 6 |
| Xiao Jun Zhu | 4 |
| Yu Liu | 3 |
| Lin Hou | 2 |
| Le Lan Tao | 2 |
| Qiu Mei Mo | 2 |
| Jian Cao | 2 |
| Lan Bo Feng | 2 |
| Xiao Qing Li | 2 |
| Wen Fa Cao | 2 |
| Wei Xing Jiang | 1 |
| Li Ping Cao | 1 |
| Qi Li Li | 1 |
| Tie Long Liu | 1 |
- Börse
- Insiders
- Kai Hai Shao
- Unternehmensverbindungen
